PMID- 34583417 OWN - NLM STAT- MEDLINE DCOM- 20211203 LR - 20211214 IS - 1099-0496 (Electronic) IS - 1099-0496 (Linking) VI - 56 IP - 12 DP - 2021 Dec TI - Laboratory parameters between multisystem inflammatory syndrome in children and Kawasaki disease. PG - 3688-3698 LID - 10.1002/ppul.25687 [doi] AB - Multisystem inflammatory syndrome in children (MIS-C) associated with coronavirus disease 2019 (COVID-19) has been described to partially overlap with Kawasaki disease (KD) with regard to clinical symptoms, but they are unlikely to share the same disease entity. We conducted a systematic review and meta-analysis to characterize the laboratory parameters of MIS-C compared with those of KD and Kawasaki disease shock syndrome (KDSS). Databases were searched for studies on laboratory parameters of MIS-C (hematology, inflammatory markers, cardiac markers, and biochemistry) through May 31, 2021. Twelve studies with 3073 participants yielded 969 MIS-C patients. In terms of hematology, MIS-C patients had lower levels of leukocytes, absolute lymphocyte count and platelet count (PLT) than KD patients and had similar absolute neutrophil count (ANC) and hemoglobin (Hb) levels. In terms of inflammatory markers, MIS-C patients had higher levels of C-reactive protein, D-dimer and ferritin than KD patients and had similar levels of procalcitonin and erythrocyte sedimentation rate (ESR). In terms of cardiac markers, MIS-C patients had higher CPK levels than KD patients. The levels of N-terminal pro-brain natriuretic peptide, troponin and aspartate aminotransferase were not significantly different between MIS-C and KD patients. In terms of biochemistry, MIS-C patients had lower levels of albumin, sodium and alanine aminotransferase and higher levels of creatinine than KD patients. In addition, MIS-C patients had lower levels of PLT, Hb and ESR and higher levels of ANC than KDSS patients. Measurement of laboratory parameters might assist clinicians with accurate evaluation of MIS-C and further mechanistic research. CI - (c) 2021 Wiley Periodicals LLC. FAU - Zhou, Chunling AU - Zhou C AD - Department of Pediatrics, People's Hospital of Chongqing Banan District, Chongqing, China. FAU - Zhao, Yan AU - Zhao Y AUID- ORCID: 0000-0002-8244-6297 AD - Department of Pediatrics, People's Hospital of Chongqing Banan District, Chongqing, China. FAU - Wang, Xia AU - Wang X AD - Department of Pediatrics, Chongqing Youyoubaobei Women and Children's Hospital, Chongqing, China. FAU - Huang, Ying AU - Huang Y AD - Department of Respiratory Medicine, Children's Hospital of Chongqing Medical University, Chongqing, China. FAU - Tang, Xuewen AU - Tang X AD - Department of Cardiology, People's Hospital of Chongqing Banan District, Chongqing, China. FAU - Tang, Lei AU - Tang L AD - Department of Pediatrics, People's Hospital of Chongqing Banan District, Chongqing, China. LA - eng PT - Journal Article PT - Meta-Analysis PT - Systematic Review DEP - 20210928 PL - United States TA - Pediatr Pulmonol JT - Pediatric pulmonology JID - 8510590 RN - pediatric multisystem inflammatory disease, COVID-19 related SB - IM MH - *COVID-19/complications MH - Child MH - Humans MH - Laboratories MH - *Mucocutaneous Lymph Node Syndrome/complications/diagnosis MH - SARS-CoV-2 MH - Systemic Inflammatory Response Syndrome OTO - NOTNLM OT - COVID-19 OT - Kawasaki disease OT - Kawasaki disease shock syndrome OT - MIS-C OT - PIMS-TS OT - PMIS OT - SARS-CoV-2 OT - children OT - laboratory parameters OT - meta-analysis EDAT- 2021/09/29 06:00 MHDA- 2021/12/15 06:00 CRDT- 2021/09/28 20:33 PHST- 2021/08/26 00:00 [revised] PHST- 2021/07/14 00:00 [received] PHST- 2021/09/18 00:00 [accepted] PHST- 2021/09/29 06:00 [pubmed] PHST- 2021/12/15 06:00 [medline] PHST- 2021/09/28 20:33 [entrez] AID - 10.1002/ppul.25687 [doi] PST - ppublish SO - Pediatr Pulmonol. 2021 Dec;56(12):3688-3698. doi: 10.1002/ppul.25687. Epub 2021 Sep 28.